openPR Logo
Press release

Global Erythropoietin (EPO) Market With Focus On Asia: Industry Analysis & Outlook (2016-2020)

12-01-2016 03:01 PM CET | Health & Medicine

Press release from: Erythropoietin

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle and brain’s response to neuronal injury. People suffering from End Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology.

On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs.

The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies.

The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)” analyzes the development of this market, with focus on the US and Asia-Pacific markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson & Johnson, Amgen, Roche and Teva Pharmaceutical Industries Limited are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global EPO market along with the study of the regional markets.

Download Sample copy of Report at http://www.marketresearchreports.biz/sample/sample/862810

Table of Content

1. Overview
1.1 Erythropoietin
1.2 Recombinant Human Erythropoietin (rHuEPO)
1.3 Applications of EPO and Adverse Effects

2. Global EPO Market
2.1 Global EPO Drug Market by Value
2.2 Global EPO Drug Market Forecast by Value
2.3 Global EPO Biosimilar Market by Value
2.4 Global EPO Biosimilar Market Forecast by Value
2.5 Global EPO Market by Drug Type
2.6 Global EPO Drug Market Forecast by Application
2.7 Global EPO Drug Market by Region

3. Regional Markets
3.1 The US
3.1.1 The US EPO Drug Market Forecast by Value
3.1.2 The US EPO Drugs Market by Applications
3.2 Asia-Pacific
3.2.1 China EPO Drug Market by Value
3.2.2 China EPO Drug Market Forecast by Value
3.2.3 China EPO Drug Market by Application
3.2.4 Malaysia EPO Drug Market Forecast by Value
3.2.5 Korea EPO Drug Market Forecast by Value
3.2.6 Thailand EPO Drug Market Forecast by Value
3.2.7 Philippines EPO Drug Market Forecast by Value
3.2.8 Vietnam EPO Drug Market Forecast by Value

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Erythropoietin (EPO) Market With Focus On Asia: Industry Analysis & Outlook (2016-2020) here

News-ID: 389647 • Views:

More Releases from Erythropoietin

Global erythropoietin Market Report 2019 Companies included Amgen, Johnson & Johnson, Roche, Galenica, Emcure and Others
Global erythropoietin Market Report 2019 Companies included Amgen, Johnson & Joh …
#7th Edition erythropoietin market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global erythropoietin market report: sales@marketreportscompany.com The erythropoietin market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth analysis of numerous
Global erythropoietin Market Report 2018 Companies included F. Hoffmann-La Roche, Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Hospira and Others
Global erythropoietin Market Report 2018 Companies included F. Hoffmann-La Roche …
We have recently published market research report on erythropoietin . For inquiry email us at: sales@marketreportscompany.com Report includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR. The report also provides detailed segmentation on the basis of product type, applications and regional segmentation. The regional segment is further
Erythropoietin Market Report 2018 Companies included Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences and Others
Erythropoietin Market Report 2018 Companies included Amgen, Johnson & Johnson, R …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides

All 4 Releases


More Releases for EPO

Global EPO Biomarkers Market Share: Trends, Key Players, Industry Analysis Repor …
The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfa
EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 20 …
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancer
EPO Biomarkers Market : Industry Research, Study, Growth Analysis Report 2019 & …
Researchmoz added Most up-to-date research on “Global EPO Biomarkers Market Size, Status and Forecast 2019-2025” to its huge collection of research reports. The EPO Biomarkers market report [6 Year Forecast 2019-2025] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin …
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in